(Q45763094)

15 December 2017

title

Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice (English)

1 reference

15 December 2017

1 reference

1 reference

placebo-controlled trial

1 reference

1 reference

Akbar SM

1

1 reference

15 December 2017

Kajino K

2

1 reference

15 December 2017

Tanimoto K

3

1 reference

15 December 2017

Kurose K

4

1 reference

15 December 2017

Masumoto T

5

1 reference

15 December 2017

Michitaka K

6

1 reference

15 December 2017

Horiike N

7

1 reference

15 December 2017

Onji M

8

1 reference

15 December 2017

publication date

1 January 1997

1 reference

15 December 2017

published in

Journal of Hepatology

1 reference

15 December 2017

volume

26

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

page(s)

131-137

1 reference

15 December 2017

Chronic type B hepatitis and the "healthy" HBsAg carrier state

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

Interferon in the management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

Specific vaccine therapy in chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

Expression and replication of hepatitis B virus genome in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

The cellular basis for lack of antibody response to hepatitis B vaccine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980019-0

7 January 2021

10.1016/S0168-8278(97)80019-0

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

9148003

1 reference

15 December 2017